Jon D. Morrow, MD, MBA

Jon D. Morrow, MD, MBA

Affiliated Provider

Specialty: Obstetrics

Treats: Adults

Languages: English, French

Phone: 212-263-5640

View Locations

Credentials

Positions

Clinical Associate Professor, Department of Obstetrics and Gynecology at NYU Grossman School of Medicine

Board Certifications

American Board of Obstetrics & Gynecology - Obstetrics & Gynecology, 1995

Education and Training

MBA from Columbia University, 2002
Residency, Northwestern University - Prentice Women's Hospital, Obstetrics & Gynecology, 1993
MD from McGill University, 1989

Is this your profile?

Edit profile

Insurance Plans Accepted

Please call the office for information about accepted insurance plans.

Jon D. Morrow, MD, MBA does not accept insurance.

Locations and Appointments

Tisch Hospital, Labor & Delivery

550 First Avenue, 8th Floor, New York, NY 10016

View Map

Phone

212-263-5640

Research My Research

Interests

informatics, EMR usability, overactive bladder, OAB, healthcare IT , clinical workflows, EHR usability, user-interface design, quality improvement, medical quality, labor & delivery, synthetic data

Academic office

550 First Avenue

TH8

New York, NY 10016

Phone

212-263-5640

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *

represents one publication

*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Publications

Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: Results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)

Thomas, Jason A; Foraker, Randi E; Zamstein, Noa; Morrow, Jon D; Payne, Philip R O; Wilcox, Adam B

Journal of the American Medical Informatics Association. 2022 Jul 12; 29(8):1350-1365
Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials

DuBeau, Catherine E; Morrow, Jon D; Kraus, Stephen R; Creanga, Dana; Bavendam, Tamara

Neurourology & urodynamics. 2012 Nov ; 31(8):1258-65
The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptoms

Staskin, David R; Michel, Martin C; Sun, Franklin; Guan, Zhonghong; Morrow, Jon D

Journal of urology. 2012 May ; 187(5):1721-6

Read All Publications (13)

Care & Services

Locations

Conditions We Treat

Patient & Visitor Support

Jon D. Morrow, MD, MBA

Credentials

Positions

Board Certifications

Education and Training

Insurance Plans Accepted

Locations and Appointments

Tisch Hospital, Labor & Delivery

Phone

Research My Research

Interests

Academic Contact

Academic office

Phone

Research Interests Timeline

Publications

Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: Results from analyzing >1.8 million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C)

Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials

The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptoms